Novel g proteins, polynucleotide encoding the same and utilization thereof
CA 2432968 A1 · Owner: Takahashi, Yasuhiko · Inventors: Matsumoto, Yasuo; Oeda, Kenji; Takahashi, Yasuhiko
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
We identified a novel protein (Gm1) comprising an amino acid sequence part having a high homology with a domain having a high homology with a GTP binding site and a GTPase site conserved among G protein .alpha. subunits and a trimer forming domain conserved among G protein .alpha. subunits. The Gm1 is involved in an signal transduction via a G protein-coupled receptor (GPCR) stimulation. Accordingly this protein is considered to be a novel G protein. The Gm1 is expressed intensively in human brainy thymus testes, spleen, small intestine, uterus and heart. We also established a method for screening for a substance capable of regulating a cellular signal transduction employing a …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 10, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 10, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 10, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.